Analyst Research and Ratings: ADOMANI, Inc. (ADOM), EnSync, Inc. (ESNC)

ADOMANI, Inc. (NASDAQ:ADOM) tinted gains of +27.89% (+0.11 points) to US$0.49. The volume of 4.09 Million shares climbed down over an trading activity of 524.17 Million shares. EPS ratio determined by looking at last 12 month figures is -0.14. Over the same time span, the stock marked US$1.97 as its best level and the lowest price reached was US$0.16. The corporation has a market cap of US$36.93 Million.

ADOMANI, Inc. (NASDAQ:ADOM)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -126.9 percent while most common profitability ratio return on investment (ROI) was -490.9 percent. The company’s institutional ownership is monitored at 3.1 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 1 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 2. 3 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

EnSync, Inc. (NYSE:ESNC) is worth US$8.55 Million and has recently risen 46.56% to US$0.13. The latest exchange of 31.45 Million shares is below its average trading activity of 887.28 Million shares. The day began at US$0.1 but the price moved to US$0.1 at one point during the trading and finally capitulating to a session high of US$0.16. The stock tapped a 52-week high of US$0.46 while the mean 12-month price target for the shares is US$1.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 1.44, and a price to sales ratio of 0.69. For the past 5 years, the company’s revenue has grown 9.1%, while the company’s earnings per share has grown 20.3%. With an institutional ownership near 6.6%, it carries an earnings per share ratio of -0.21.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 2 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.